학술논문

Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Document Type
article
Author
Kabisch, MariaBermejo, Justo LorenzoDünnebier, ThomasYing, ShiboMichailidou, KyriakiBolla, Manjeet KWang, QinDennis, JoeShah, MitulPerkins, Barbara JCzene, KamilaDarabi, HatefEriksson, MikaelBojesen, Stig ENordestgaard, Børge GNielsen, Sune FFlyger, HenrikLambrechts, DietherNeven, PatrickPeeters, StephanieWeltens, CarolineCouch, Fergus JOlson, Janet EWang, XianshuPurrington, KristenChang-Claude, JennyRudolph, AnjaSeibold, PetraFlesch-Janys, DieterPeto, Juliandos-Santos-Silva, IsabelJohnson, NicholaFletcher, OliviaNevanlinna, HeliMuranen, Taru AAittomäki, KristiinaBlomqvist, CarlSchmidt, Marjanka KBroeks, AnnegienCornelissen, StenHogervorst, Frans BLLi, JingmeiBrand, Judith SHumphreys, KeithGuénel, PascalTruong, ThérèseMenegaux, FlorenceSanchez, MarieBurwinkel, BarbaraMarmé, FrederikYang, RongxiBugert, PeterGonzález-Neira, AnnaBenitez, JavierZamora, M PilarPerez, Jose I AriasCox, AngelaCross, Simon SReed, Malcolm WRAndrulis, Irene LKnight, Julia AGlendon, GordTchatchou, SandrineSawyer, Elinor JTomlinson, IanKerin, Michael JMiller, NicolaHaiman, Christopher ASchumacher, FredrickHenderson, Brian ELe Marchand, LoicLindblom, AnnikaMargolin, SaraHooning, Maartje JHollestelle, AntoinetteKriege, MiekeKoppert, Linetta BHopper, John LSouthey, Melissa CTsimiklis, HelenApicella, CarmelSlettedahl, SethToland, Amanda EVachon, CelineYannoukakos, DrakoulisGiles, Graham GMilne, Roger LMcLean, CatrionaFasching, Peter ARuebner, MatthiasEkici, Arif BBeckmann, Matthias WBrenner, HermannDieffenbach, Aida KArndt, VolkerStegmaier, ChristaAshworth, AlanOrr, NicholasSchoemaker, Minouk JSwerdlow, Anthony
Source
Carcinogenesis. 36(2)
Subject
Cancer
Human Genome
Prevention
Breast Cancer
Genetics
Aetiology
2.1 Biological and endogenous factors
3' Untranslated Regions
Aurora Kinase B
Breast Neoplasms
Case-Control Studies
Cell Cycle Proteins
Chromosomal Proteins
Non-Histone
Female
Genetic Predisposition to Disease
Genome-Wide Association Study
Humans
Inhibitor of Apoptosis Proteins
Polymorphism
Single Nucleotide
Receptors
Estrogen
Risk
Survivin
White People
kConFab Investigators
Australian Ovarian Cancer Study Group
GENICA Network
Oncology and Carcinogenesis
Oncology & Carcinogenesis
Language
Abstract
The chromosomal passenger complex (CPC) plays a pivotal role in the regulation of cell division. Therefore, inherited CPC variability could influence tumor development. The present candidate gene approach investigates the relationship between single nucleotide polymorphisms (SNPs) in genes encoding key CPC components and breast cancer risk. Fifteen SNPs in four CPC genes (INCENP, AURKB, BIRC5 and CDCA8) were genotyped in 88 911 European women from 39 case-control studies of the Breast Cancer Association Consortium. Possible associations were investigated in fixed-effects meta-analyses. The synonymous SNP rs1675126 in exon 7 of INCENP was associated with overall breast cancer risk [per A allele odds ratio (OR) 0.95, 95% confidence interval (CI) 0.92-0.98, P = 0.007] and particularly with estrogen receptor (ER)-negative breast tumors (per A allele OR 0.89, 95% CI 0.83-0.95, P = 0.0005). SNPs not directly genotyped were imputed based on 1000 Genomes. The SNPs rs1047739 in the 3' untranslated region and rs144045115 downstream of INCENP showed the strongest association signals for overall (per T allele OR 1.03, 95% CI 1.00-1.06, P = 0.0009) and ER-negative breast cancer risk (per A allele OR 1.06, 95% CI 1.02-1.10, P = 0.0002). Two genotyped SNPs in BIRC5 were associated with familial breast cancer risk (top SNP rs2071214: per G allele OR 1.12, 95% CI 1.04-1.21, P = 0.002). The data suggest that INCENP in the CPC pathway contributes to ER-negative breast cancer susceptibility in the European population. In spite of a modest contribution of CPC-inherited variants to the total burden of sporadic and familial breast cancer, their potential as novel targets for breast cancer treatment should be further investigated.